BoneSupport receives FDA market authorization for antibiotic-eluting bone graft
BoneSupport has announced FDA market authorization of the Cerament G bone graft for patients with osteomyelitis, according to a press release.The Cerament G bone graft, which is protected by locally eluted antibiotics, is designed to facilitate bone healing and reduce the risk of reinfection and amputation, according to the release.